4LXB

Crystal Structure Analysis of thrombin in complex with compound D58

Summary for 4LXB
Related4LOY
DescriptorProthrombin, Thrombin light chain, Hirudin variant-1, Prothrombin, ... (7 entities in total)
Functional Keywordsserine proteases, antithrombotic agents, dual thrombin/factor xa inhi, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight36455.75
Authors
Stehlin-Gaon, C.,Bocskei, Z. (deposition date: 2013-07-29, release date: 2014-06-11, Last modification date: 2020-07-29)
Primary citationAlet, N.,Altenburger, J.M.,Barre, G.,Bocskei, Z.,Bono, F.,Briot, C.,Dol, F.,Florian, P.,Follmann, M.,Herault, J.P.,Herbert, J.M.,Klieber, S.,Lassalle, G.,Meneyrol, J.,Millet, L.,Petit, F.,Rousseaux, T.,Sadoun, F.,Schaeffer, P.,Schreuder, H.,Wehner, V.
5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.
J.Med.Chem., 56:9441-9456, 2013
PubMed: 24175584
DOI: 110.1021/jm4005835
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.61 Å)
Structure validation
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB Foundation
wwPDBRCSB PDBPDBeBMRBAdv. SearchSearch help

179210

PDB entries from 2021-06-23